期刊文献+

溶血危象并输血困难1例

A case of hemolytic crisis with difficult in blood transfusion
原文传递
导出
摘要 溶血危象患者多表现为在数小时至数天内发生的血红蛋白明显下降,疾病的发生、发展非常急骤,严重者可发生弥散性血管内凝血(DIC)合并多器官损伤,对患者生命造成威胁。本文报道1例发生溶血危象并输血困难的患者,通过稀释法鉴定不规则抗体筛查,选择ABO和Rh分型一致的去白细胞悬浮红细胞联合血浆置换治疗的病例。1 资料与方法1.1 资料患者,女,36岁,入院前3 d无明显诱因出现头痛,无喷嚏流涕、咳嗽咳痰、腹痛腹泻、尿频尿痛及腰痛等。 In patients with hemolytic crisis, the hemoglobin is often significantly reduced within a few hours to a few days, and the development of the disease is very rapid.In severe cases, disseminated intravascular coagulation(DIC) combined with multiple organ damage may threaten the lives of patients.This article reports a case of a patient with hemolytic crisis and difficulty in blood transfusion.The dilution method was used to identify irregular antibody screening and selected leukocyte-removed suspended red blood cells with consistent ABO and Rh group combined with plasma exchange therapy.
作者 杨菁菁 张鹏 雒红玉 YANG Jingjing;ZHANG Peng;LUO Hongyu
出处 《临床血液学杂志》 CAS 2021年第12期887-889,共3页 Journal of Clinical Hematology
关键词 溶血危象 输血治疗方案 hemolytic crisis blood transfusion treatment plan
  • 相关文献

参考文献3

二级参考文献11

  • 1Mansouri Taleghani B, Strasser E. Therapeutic hemapheresis[J]. Transfus Med Hemother, 2012, 39(4): 232-233.
  • 2Griesshammer M, Gisslinger H, Mesa R. Current and future treatment options for polycythemia vera[J]. Ann Hematol, 2015, 94(6): 901-910.
  • 3Nouraie M, Lee JS, Zhang Y, et al. The relationship between the severity of hemolysis clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe[J]. Haematologica, 2013, 98(3): 464-472.
  • 4Silvergleid AJ. Applications and limitations of hemapheresis[J]. Annu Rev Med, 1983, 34: 69-89.
  • 5Mascarenhas J, Mesa R, Prchal J, et al. Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials[J]. Haematologica, 2014, 99(6): 945-949.
  • 6Golden PJ. Therapeutic hemapheresis practitioners need to know about the treatment of thrombotic thrombocytopenic purpura[J]. Transfus Apher Sci, 2003, 28(3): 215-217.
  • 7Amancio J, Scuro G, Gazoni FM, et al. Chronicle myeloid leukemia and hiperviscosity syndrome: case report[J]. Rev Bras Ter Intensiva, 2008, 20(1): 99-102.
  • 8Haupt WF, Rosenow F, van der Ven C, et al. Immunoadsorption in Guillain-barre syndrome and myasthenia gravis[J]. Ther Apher, 2000, 4(3): 195-197.
  • 9van Doom PA, Ruts L, Jacobs BC. Clinical features pathogenesis and treatment of Guillain-Barre syndrome[J]. Lancet Neurol, 2008, 7(10): 939-950.
  • 10Baskin E, Gulleroglu K, Kantar A, et al. Success of eculizumab in the treatment of atypical hemolytic uremic syndrome[J]. Pediatric Nephrology(Berlin, Germany), 2015, 30(5): 783-789.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部